The Journal of Clinical Endocrinology & Metabolism · 2008 · 30 citations · 33 references
Life SciencesGeneticsMolecular GeneticsGenetic CounselingMedical GeneticsNeoplasiaGenetic DisordersGenetic Risk AssessmentGermline Variant InterpretationRare Disease GeneticsGenetic TestingGenetic Testing Of At-risk RelativesGermline MutationsImprintingMutationParaganglioma GeneticsParaganglioma SyndromesWhole-body Magnetic Resonance Imaging
CONTEXT AND OBJECTIVE: Germline mutations of the genes SDHB, SDHC, and SDHD predispose to paraganglioma syndromes. Mutation-specific counseling, risk assessment, and management recommendations ideally should be performed. Here, we provide data for a single common mutation of the SDHD gene. METHODS: The European-American Pheochromocytoma-Paraganglioma Registry served as the source for unrelated index cases affected by pheochromocytoma or paraganglioma. Patients with the SDHD c.33 C-->A (p.Cys11X) germline mutations were reinvestigated by whole-body magnetic resonance imaging and 24-h urinary catecholamine assay. First-degree relatives underwent genetic testing and those testing positive had same clinical investigations. Microsatellite analyses were used to test the hypothesis that all index cases were related and the mutation is a founding one. RESULTS: Sixteen index cases with the mutation SDHD p.Cys11X are registered. After testing their relatives, there were a total of 25 mutation carriers. We excluded seven subjects who inherited the mutation from the mother because of maternal imprinting. Thus, 18 mutation carriers were clinically affected. Among these 16 (89%) had head and neck paragangliomas, six (33%) thoracic tumors, six (33%) extraadrenal retroperitoneal, and five (28%) intraadrenal. Of note, 16 (89%) had multiple tumors at first diagnosis, and one (5%) had signs of malignancy during follow-up. Overall penetrance was 100% at age 54. Haplotype analyses revealed evidence for a founder effect. CONCLUSIONS: The SDHD p.Cys11X mutation is a founding mutation associated with a high penetrance for paraganglial tumors of the skull base, neck, thorax, and retroperitoneum in the first four decades of life and, rarely, with malignancy.
33
Harrison's Principles of Internal Medicine.
Annals of Internal Medicine · 1988 · 12.6K citations
A high-resolution recombination map of the human genome
Augustine Kong, Daníel F. Guðbjartsson, Jesús Sainz et al. · Nature Genetics · 2002 · 1.8K citations
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Hartmut P.H. Neumann, Birke Bausch, Sarah R. McWhinney et al. · New England Journal of Medicine · 2002 · 1.4K citations · Full text